Cofoe Medical Technology Co., Ltd. (abbrev. “COFOE”) has finalised the terms of its Hong Kong IPO, offering 27.00 million H shares at HK$39.33 each. The transaction delivers gross proceeds of HK$1.06 billion and net proceeds of HK$1.01 billion after estimated expenses. Trading is scheduled to commence on 6 May 2026 under the stock short name “COFOE”.

Offer structure and demand • Hong Kong Public Offering: 2.70 million shares (10 % of deal size) drew 105,939 valid applications, translating into 399.08 times oversubscription. • International Offering: 24.30 million shares (90 %) were 3.4 times subscribed across 129 placees. • No over-allotment option was granted; no post-listing stabilisation will be undertaken.

Capital base and public float Upon listing, COFOE will have 235.90 million shares in issue. The 27.00 million new H shares represent 11.67 % of the enlarged share capital, exceeding the minimum 10 % public-float requirement. After excluding cornerstone allocations subject to six-month lock-up, the free-float portion equals 17.35 million shares (7.50 % of total share capital) with an implied market value of approximately HK$682 million, satisfying the HKEX HK$600 million free-float rule.

Pricing metrics and investor mix • Cornerstone tranche: 9.65 million shares (35.76 % of the offer) were taken up by 12 investors, including Lens Technology (HK), Changsha Yufeng and Vision Capital, all subject to a six-month lock-up. • Concentration: The top 10 placees received 14.36 million shares, or 53.17 % of the total offer. The largest single placee was allocated 3.94 million shares (1.67 % of enlarged share capital). • Controlling shareholders will collectively hold 47.82 % of voting rights post-listing and are locked up for 12 months (split into two six-month periods).

Key dates and trading details • Share certificates become valid at 8:00 a.m. on 6 May 2026, with dealings in board lots of 100 H shares. • Stock code: 01187; stock short name: COFOE MEDICAL.

Regulatory compliance The company confirms adherence to HKEX Listing Rules for share allocation, public float and connected-party transactions, with waivers and consents secured where applicable.

This completes the final offer price and allotment disclosure ahead of COFOE’s debut on the Hong Kong Stock Exchange.